Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Planning finances for a growing family requires careful consideration. Learn expert tips to manage your budget effectively during this transition.
13,273 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
LRI Investments disclosed a sizable purchase of VBIL, the Vanguard 0-3 Month Treasury Bill ETF, worth about $16 milli...
A value-factor ETF has surged past the S&P 500 through February 2026, signaling a shift toward fundamentals amid vola...
Vale’s shares fell as iron ore demand in China cooled, signaling wider margin pressures for metals. This guide breaks...
Airbnb embraces AI as a growth engine, with Chesky warning competitors to adapt quickly or risk falling behind, as th...
Eight trade groups push lower capital charges for mortgage servicing rights and advocate for tailored risk weights, a...
Three Dow components power the year’s rally with double-digit gains. Honeywell’s split plan and Chevron’s rising prod...
A surge in crypto funding surging again accompanies a strategic pivot by major VCs toward infrastructure and tokenize...
Unum Group operates in the steady world of employer benefits and personal protection. If three key trends line up—und...
Two heavyweight banks reported solid Q4 2025 results, but investors remain focused on dividends, buybacks and how eac...
In a fluctuating rate environment, retirees eyeing quarterly income are increasingly turning to the Vanguard Real Est...